James E. Flynn, 10% Owner at Aclaris Therapeutics, Inc. (ACRS), sold 454,261 shares at $4.62 ($2.1M) on 2019-06-21, disclosed to the SEC on 2019-06-25.
Open-market sale of $2.1M ACRS by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $4.62 | 70,135 | $324K | 15.5% |
| 2 | $4.62 | 269,402 | $1.2M | 59.6% |
| 3 | $4.52 | 13,063 | $59K | 2.8% |
| 4 | $4.52 | 50,177 | $227K | 10.9% |
| 5 | $4.51 | 10,634 | $48K | 2.3% |
| 6 | $4.51 | 40,850 |
| $184K |
| 8.8% |
| Total | $4.59 avg | 454,261 | $2.1M | 100% |
| Filing → |
| SPRY | SELL | 2025-07-01 | $27.3M | — | Filing → |
| ONCR | SELL | 2022-12-30 | $65K | — | Filing → |
| ONCR | SELL | 2022-12-21 | $23K | — | Filing → |